DG Daiwa Ventures (DGDV) announced on the 20th that its portfolio company, US healthcare startup Allara Health, has raised $26 million in a Series B round. The round was led by Index Ventures, with participation from existing investors including GV, HOF Capital, and One Medical founder Tom Lee. DGDV has been investing in the company since its pre-Series A round. With this funding, Allara Health’s total funding has reached $38.5 million.

Allara Health provides a telemedicine platform for women with chronic conditions stemming from hormonal imbalances. It is estimated that one in three women suffers from chronic conditions such as polycystic ovary syndrome, endometriosis, and hypothyroidism, but 70% of patients do not receive proper diagnosis or treatment.

The company’s service offers personalized care plans through collaboration with specialists including obstetricians, nurses, endocrinologists, and registered dietitians. It provides comprehensive solutions for target patients, including hormone and metabolism tests and video meetings with specialists as needed.

According to the company, Allara Health’s revenue grew 4x year-over-year in 2024. Insurance coverage is also progressing through partnerships with major US healthcare insurance companies. Services have begun nationwide in the US, and DGDV plans to further support the company’s business expansion.

via PR TIMES

Adblock test (Why?)